Identification of Retinol Binding Protein 1 Promoter Hypermethylation in Isocitrate Dehydrogenase 1 and 2 Mutant Gliomas
Author(s) -
Arthur P. Chou,
Reshmi Chowdhury,
Sichen Li,
Weidong Chen,
Andrew J. Kim,
David Piccioni,
Julia Selfridge,
Reema Mody,
Stephen Chang,
Shadi Lalezari,
Jeffrey Lin,
Desiree E. Sanchez,
Ryan W. Wilson,
Matthew C. Garrett,
Bret Harry,
Jack Mottahedeh,
Phioanh L. Nghiemphu,
Harley I. Kornblum,
Paul S. Mischel,
Robert M. Prins,
William H. Yong,
Timothy F. Cloughesy,
Stanley F. Nelson,
Linda M. Liau,
Albert Lai
Publication year - 2012
Publication title -
jnci journal of the national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.797
H-Index - 356
eISSN - 1460-2105
pISSN - 0027-8874
DOI - 10.1093/jnci/djs357
Subject(s) - idh2 , isocitrate dehydrogenase , idh1 , methylation , dna methylation , biology , cancer research , cpg site , bisulfite sequencing , microbiology and biotechnology , glioma , genetics , mutant , gene , gene expression , biochemistry , enzyme
Mutations in isocitrate dehydrogenase 1 (IDH1) and associated CpG island hypermethylation represent early events in the development of low-grade gliomas and secondary glioblastomas. To identify candidate tumor suppressor genes whose promoter methylation may contribute to gliomagenesis, we compared methylation profiles of IDH1 mutant (MUT) and IDH1 wild-type (WT) tumors using massively parallel reduced representation bisulfite sequencing.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom